Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

CIR.L (CIR) Share Price

There is currently no data for CIR.L

CIR.L (CIR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
See more CIR.L trades

CIR.L (CIR) Share Price History

Time period:
to
Date Open High Low Close Volume
See more CIR.L price history

CIR.L (CIR) Regulatory News

Date Source Headline
1st Sep 2022 5:45 pm RNS Change of Company Name
1st Sep 2022 11:00 am RNS Result of General Meeting and Change of Name
11th Aug 2022 7:00 am RNS Proposed Change of Name and Notice of GM
29th Jul 2022 10:41 am RNS Total Voting Rights
21st Jul 2022 3:30 pm RNS Change of Auditor
14th Jul 2022 7:00 am RNS Trading Update
5th Jul 2022 3:57 pm RNS Holding(s) in Company
30th Jun 2022 11:54 am RNS Total Voting Rights
29th Jun 2022 11:00 am RNS Update regarding Beyond Air product approval
10th Jun 2022 1:06 pm RNS Holding(s) in Company
See more CIR.L regulatory news

CIR.L (CIR) Share News

UK shareholder meetings calendar - next 7 days

25th Aug 2022 15:55

Read More

AIM WINNERS & LOSERS: Kibo extends contract; Appreciate CEO steps down

14th Jul 2022 11:16

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More

Circassia ups guidance as revenue rises, overhead costs slashed

14th Jul 2022 10:06

(Allaince News) - Circassia Group PLC on Thursday said that its expects to outperform full-year guidance, amid "strong" revenue growth and cost cutting measures. Read More

IN BRIEF: Circassia gets USD10.5 million after BeyondAir US FDA win

29th Jun 2022 11:55

Circassia Group PLC - Oxford, England-based medical device focused on point-of-care asthma diagnosis and management - Says BeyondAir Inc has won approval from the US Food & Drug Administration for its LungFit PH device, which is used for the treatment of hypoxic respiratory failure in neonates using nitric oxide generated from ambient air. Read More

IN BRIEF: Circassia's revenue in first four months beats expectations

12th May 2022 11:23

Circassia Group PLC - Oxford, England-based medical device focused on point-of-care asthma diagnosis and management - Posts higher revenue in the first four months of 2022 than Circassia management had expected. Clinical revenue is up 17% compared to the same period in 2021. Research revenue also is slightly up, firm adds. Lockdowns may affect the business in China, but trading so far is strong with growth of over 23% there compared to a year ago. Read More

See more CIR.L news
FTSE 100 Latest
Value8,809.74
Change53.53

Login to your account

Forgot Password?

Not Registered